Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network (Q36589035)
Jump to navigation
Jump to search
scientific article published on 25 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network |
scientific article published on 25 September 2012 |
Statements
1 reference
Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network (English)
1 reference
Nancy L Keating
1 reference
Rachel A Freedman
1 reference
Melissa E Hughes
1 reference
Rebecca A Ottesen
1 reference
Jane C Weeks
1 reference
Yulei He
1 reference
Yu-Ning Wong
1 reference
Richard Theriault
1 reference
25 September 2012
1 reference
1 reference
839-846
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference